Paradoxical Cerebral Embolization Caused by Thrombus-In-Transit via a Patent Foramen Ovale in a Patient with Symptomatic Pulmonary Embolism: A Case Report.
cryptogenic stroke
paradoxical embolization
pulmonary embolism
thrombus-in-transit
Journal
Journal of neuroendovascular therapy
ISSN: 2186-2494
Titre abrégé: J Neuroendovasc Ther
Pays: Japan
ID NLM: 101488164
Informations de publication
Date de publication:
2021
2021
Historique:
received:
14
01
2021
accepted:
15
02
2021
medline:
1
1
2021
pubmed:
1
1
2021
entrez:
28
7
2023
Statut:
ppublish
Résumé
Acute pulmonary embolism (PE) is a life-threatening cardiovascular event associated with high mortality and morbidity. The presence of a patent foramen ovale (PFO) in patients with acute PE represents a risk factor for mortality. Furthermore, a thrombus-in-transit via a PFO with impending paradoxical embolism carries a high mortality rate. An adult patient with ischemic stroke caused by paradoxical embolism following PE underwent mechanical thrombectomy and achieved successful recanalization. Initial CT pulmonary angiography (CTPA) showed not only pulmonary thromboemboli but also bilateral atrial thromboemboli. During hospitalization, transesophageal echocardiography (TEE) revealed the PFO with a right-to-left shunt. Two months after rehabilitation undergone by the patient, PE completely disappeared and PFO closure was conducted to reduce the recurrence risk of ischemic stroke. Not only cardiologists but also interventional neurologists should understand that CTPA can demonstrate the thrombus-in-transit through the PFO and provides a reliable prediction of the sudden onset of ischemic stroke in patients with symptomatic PE. When identified, considering a case-by-case treatment approach by multidisciplinary teams is essential for preventing further life-threatening paradoxical embolization.
Identifiants
pubmed: 37502001
doi: 10.5797/jnet.cr.2021-0003
pii: jnet.cr.2021-0003
pmc: PMC10370931
doi:
Types de publication
Case Reports
Langues
eng
Pagination
805-810Informations de copyright
©2021 The Japanese Society for Neuroendovascular Therapy.
Déclaration de conflit d'intérêts
All authors declare no conflicts of interest.
Références
J Cardiovasc Comput Tomogr. 2018 Jul - Aug;12(4):271-274
pubmed: 29217343
Am J Med. 2015 Jul;128(7):747-59.e2
pubmed: 25680885
J Cardiol Cases. 2018 Sep 27;19(1):19-21
pubmed: 30693053
J Thorac Dis. 2018 Apr;10(4):2338-2345
pubmed: 29850139
Int Heart J. 2017 Oct 21;58(5):812-815
pubmed: 28966317
N Engl J Med. 2017 Sep 14;377(11):1022-1032
pubmed: 28902590
Vasc Med. 2015 Apr;20(2):131-8
pubmed: 25832601
Catheter Cardiovasc Interv. 2018 Jul;92(1):176-186
pubmed: 29726616
Gac Med Mex. 2017 Jan-Feb;153(1):129-133
pubmed: 28128817
J Am Coll Cardiol. 2003 Jun 18;41(12):2245-51
pubmed: 12821255
Chest. 2017 Feb;151(2):409-416
pubmed: 27746202
Eur Neurol. 2015;74(1-2):69-72
pubmed: 26228469
Ann Intern Med. 2019 Jun 4;170(11):756-763
pubmed: 31060047